The SYNAPSE team is delighted to announce the launch of a new Horizon 2020 project, the HTx Project, which will operate in Europe for the coming five years, 2019 – 2023.
The overall objective of HTx is to create a framework for next generation Health Technology Assessment that supports patient-centred, societally oriented, real-time decision-making for integrated healthcare throughout Europe.
The mission of HTx is to facilitate the development of methodologies to deliver more customized information on the effectiveness and cost-effectiveness of complex and personalised combinations of health technologies. HTx will also provide methods to support personalised treatment advice that will be shared with patients and their physicians.
HTx aims also to work in close collaboration with the European Network for HTA (EUnetHTA) and its stakeholders to pilot the implementation of these methods in Europe.
The HTx consortium comprises fifteen partners, including academia, Univeristies, patient associations, SME’s, regulatory authorities and National Health Institutes, led by Utrecht University (The Netherlands).
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the call BETTER HEALTH AND CARE, ECONOMIC GROWTH AND SUSTAINABLE HEALTH SYSTEMS.
To read press release click here